Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33631016

A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Neuro Oncol
Publication date
2021 Oct 1
First author
Fangusaro J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Neuro Oncol. 2021 Oct 1;23(10):1627-1628. doi: 10.1093/neuonc/noab164.
    note
    Source null
    related pmid
    34251024
    relationship
    Comment in

Authors and identifiers

  1. name
    Fangusaro J
    type
    Author
  2. name
    Onar-Thomas A
    type
    Author
  3. name
    Poussaint TY
    type
    Author
  4. name
    Wu S
    type
    Author
  5. name
    Ligon AH
    type
    Author
  6. name
    Lindeman N
    type
    Author
  7. name
    Campagne O
    type
    Author
  8. name
    Banerjee A
    type
    Author
  9. name
    Gururangan S
    type
    Author
  10. name
    Kilburn LB
    type
    Author
  11. name
    Goldman S
    type
    Author
  12. name
    Qaddoumi I
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fangusaro J
    type
    Author
  2. name
    Onar-Thomas A
    type
    Author
  3. name
    Poussaint TY
    type
    Author
  4. name
    Wu S
    type
    Author
  5. name
    Ligon AH
    type
    Author
  6. name
    Lindeman N
    type
    Author
  7. name
    Campagne O
    type
    Author
  8. name
    Banerjee A
    type
    Author
  9. name
    Gururangan S
    type
    Author
  10. name
    Kilburn LB
    type
    Author
  11. name
    Goldman S
    type
    Author
  12. name
    Qaddoumi I
    type
    Author
bibliography ids
  1. nci-bib-fcc9f53d9652cf6acc8bae1f
book metadata
content sha256
4d1eed00bd09b4b3b65debc5541afb296befd7a5daea73e37b929408e3567015
document type
citation
dois
  1. 10.1093/neuonc/noab047
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33631016
immutable id
pubmed:33631016@4d1eed00bd09b4b3b65debc5541afb296befd7a5daea73e37b929408e3567015
journal
abbreviation
Neuro Oncol
issn electronic
1523-5866
issn print
1522-8517
issue
10
name
Neuro-oncology
nlm unique id
100887420
pages
1777-1788
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Neuro Oncol. 2021 Oct 1;23(10):1627-1628. doi: 10.1093/neuonc/noab164.
    note
    Source null
    related pmid
    34251024
    relationship
    Comment in
outcomes validated
false
pmid
33631016
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
1249b39c3ca1d4b95c4629e2037a2a15dc56e5659f09382a14468f958d038f94
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Oct 1
precision
day
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33631016/
title
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.

Preserved source evidence · Not medical advice